Source,TTY

 1  HHC96IN|         and monitor antineoplastic agents.~Chest Physiotherapy [C0199467] [
 2  NIC96AC|          Administer antiarrhythmic agents, as appropriate [C0508212] [
 3  NIC96AC|        Administer antiinflammatory agents and/or bronchodilators,
 4  NIC96AC|               Administer microbial agents and bronchodilators, as
 5  NIC96AC|             Administer mucokinetic agents, as appropriate [C0508310] [
 6  NIC96AC|       Administer muscle-paralyzing agents, sedatives, and narcotic
 7  NIC96AC|            oral or parenteral HCO3 agents, if appropriate [C0508315] [
 8  NIC96AC|         Administer pharmacological agents to increase urinary output,
 9  NIC96AC|         Administer pharmacological agents to maintain ICP within specified
10  NIC96AC|         Administer pharmacological agents to maintain hemodynamic
11  NIC96AC|         Administer pharmacological agents to replace chloride, as
12  NIC96AC|      Administer positive inotropic agents, as appropriate [C0508329] [
13  NIC96AC|         fluids and vasoconstrictor agents, as indicated, to facilitate
14  NIC96AC|            prescribed antidiuretic agents (e.g., desmopressin/DDAVP
15  NIC96AC|               Administer rheologic agents [e.g., low-dose Mannitol
16  NIC96AC|             neuromuscular-blocking agents (only if patient is mechanically
17  NIC96AC| antibacterial, or antiinflammatory agents to the area, as appropriate [
18  NIC96AC|          of animals as therapeutic agents [C0510012] [U001949]~----~
19  NIC96AC|      Discontinue use of triggering agents [C0510225] [U002164]~----~
20  NIC96AC|          of intermittent analgesic agents into the injection port [
21  NIC96AC|    administration of antimicrobial agents and closely monitor their
22  NIC96AC|        effects of chemotherapeutic agents [C0513363] [U005357]~----~
23  NIC96AC|     Monitor use of nonprescription agents with anticholinergic or
24  NIC96AC|            for specific anesthetic agents or techniques [C0514201] [
25  NIC96AC|      mechanical or pharmacological agents (e.g., laminaria and prostaglandin
26  NIC96AC|          skin testing to determine agents causing anaphylaxis and/
27  NIC96AC|           precipitating anesthetic agents [C0514645] [U006694]~----~
28  NIC96AC|    information about environmental agents [C0515364] [U007431]~----~
29  NIC96AC|          effects of pain-relieving agents [C0516082] [U008159]~----~
30  NIC96AC|     U008376]~----~Use fibrinolytic agents to open occluded VAD, as
31  NIC96HC|           effects of pharmacologic agents~Electrolyte and Acid-Base
32  NIC96PT|         2210]~Use of pharmacologic agents to reduce or eliminate pain~
33  NIC96PT|    Administration of pharmacologic agents into the epidural or intrathecal
34  NIC96PT|       administration of anesthetic agents, and monitoring of patient
35  NIC96PT|          effects of antineoplastic agents~Chest Physiotherapy [C0199467] [
36  NIC96PT|         transmission of infectious agents~Infection Control: Intraoperative [
37  NIC96PT|        response to pharmacological agents used during surgery~Mechanical
38  NIC96SA|           U000037]~----~Administer agents to expand intravascular
39  NIC96SA|      inotropic or vasoconstrictive agents, as ordered, to maintain
40  NIC96SA|           nontriggering anesthetic agents for surgical patients with
41  NOC97ID|         for interaction with other agents [C0517794] [180809]~----~
42  OMS94SI|    infectious and/or contaminating agents [C0237141] [P2S09]~----~
43 PCDS97OR|          receiving anti-arrhythmic agents. [C0547705] [ORC_08430.00]~----~
44 PCDS97OR|          Chemotherapy - Alkylating Agents. [C0547724] [ORC_08560.03]~----~
45 PCDS97OR|   Chemotherapy Patient, Alkylating Agents. [C0547745] [ORC_08900.03]~----~